We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

17 hedge funds and large institutions have $8.62M invested in Champions Oncology in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

42% more funds holding

Funds holding: 12 → 17 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $11.5M → $8.62M (-$2.93M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$123K
2
VKH
Virtu KCG Holdings
New York
+$62.4K
3
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$52.1K
4
Millennium Management
Millennium Management
New York
+$41.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$29.5K

Top Sellers

Rank Fund Capital Flow
1
PCM
PAR Capital Management
Massachusetts
-$768K
2
SM
Sabby Management
Florida
-$15.1K
3
Morgan Stanley
Morgan Stanley
New York
-$6K
4
UBS Group
UBS Group
Switzerland
-$785
Name Holding Trade Value Shares
Change 		Change in
Stake
BPI
1
Battery Partners IX
Massachusetts
$3.28M – – –
NMC
2
NEA Management Company
Maryland
$2.63M – – –
SM
3
Sabby Management
Florida
$905K -$15.1K -8,135 -1%
PCM
4
PAR Capital Management
Massachusetts
$646K -$768K -412,618 -52%
PA
5
Perceptive Advisors
New York
$625K – – –
KCM
6
Knoll Capital Management
Florida
$184K – – –
Goldman Sachs
7
Goldman Sachs
New York
$111K +$123K +66,302 New
VKH
8
Virtu KCG Holdings
New York
$56K +$62.4K +33,533 New
SKK
9
Shepherd Kaplan Krochuk
Massachusetts
$47K +$52.1K +28,000 New
Millennium Management
10
Millennium Management
New York
$37K +$41.5K +22,302 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$27K +$29.5K +15,840 New
BRWA
12
B. Riley Wealth Advisors
Florida
$21K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$20K +$22.2K +11,929 New
SSB
14
Sandy Spring Bank
Maryland
$14K – – –
Bank of America
15
Bank of America
North Carolina
$12K +$9.38K +5,041 +241%
UBS Group
16
UBS Group
Switzerland
$2K -$785 -422 -26%
TRCT
17
Tower Research Capital (TRC)
New York
$1K +$558 +300 +61%
Morgan Stanley
18
Morgan Stanley
New York
– -$6K -2,690 Closed

CSBR Hedge Fund Activity: Q3 2016 in Review

17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2016, worth a combined $8.62M — down 25% from $11.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CSBR positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $123K. The largest seller was PAR Capital Management, cutting an estimated $768K.

  • 17 institutional investors held Champions Oncology (CSBR) as of Q3 2016, up from 12 in Q2 2016.
  • Funds reported $8.62M of Champions Oncology stock for Q3 2016, down 25% quarter-over-quarter.
  • 6 funds opened new Champions Oncology positions in Q3 2016 and 1 closed out, a net change of +5 holders.
  • The largest Champions Oncology buyer in Q3 2016 was Goldman Sachs, an estimated $123K added.
  • The largest Champions Oncology seller in Q3 2016 was PAR Capital Management, an estimated $768K sold.

Based on aggregated 13F filings for Q3 2016.